Search results
Results from the WOW.Com Content Network
In 2021, Demasi co-authored a paper with Robert DuBroff challenging statin therapy. [16] As of 2022, Demasi is a writer for the Brownstone Institute, an organization that has been criticized by medical experts for spreading misinformation against vaccines. [17] [18]
Statins are usually used to lower blood cholesterol levels and reduce risk for illnesses related to atherosclerosis, with a varying degree of effect depending on underlying risk factors and history of cardiovascular disease. [16]
New research finds that many people currently taking statins to lower cholesterol may not actually need this medication. An analysis, published in JAMA Internal Medicine , investigates how statin ...
Aseem Malhotra is a British cardiologist, [1] health campaigner, [2] and author, who became well known during the COVID-19 pandemic after being accused of spreading misinformation about COVID-19 vaccinations. [3]
In other words, as many as 4 million people in the U.S. who currently take statins for primary prevention — meaning they have not had a cardiovascular event such as a stroke or heart attack ...
Julia Kim, 64, an IT specialist from Boston, began taking a statin more than 30 years ago because of a family history of high cholesterol. But six months ago, tired of having to take the drug and ...
The trial focused on patients with normal low-density lipoprotein (LDL) cholesterol levels but increased levels of high-sensitivity C-reactive protein (hs-CRP). JUPITER was the first clinical trial to indicate that statin therapy may provide benefit to patients with low-to-normal LDL levels and no known cardiovascular disease.
Statins are a competitive antagonists of HMG CoA, as they directly compete with the endogenous substrate for the active site cavity of HMGR. Statins are also noncompetitive with the cosubstrate NADPH (nicotinamide adenine dinucleotide phosphate). [5] By blocking the HMGR enzyme they inhibit the synthesis of cholesterol via the mevalonate pathway.